상지의 안정떨림으로 내원한 2명의 환자

참고문헌 (15)

1. Feldman M, "Updated perspectives on the management of drug-induced Parkinsonism(DIP) : insights from the clinic", Ther Clin Risk Manag, 18, pp.1129~1142 (2022)
2. Tolosa E, "DAT imaging in drug-induced and psychogenic parkinsonism", Mov Disord, 18(Suppl 7), pp.S28~S33 (2003)
3. Rajput AH, "Reversible drug-induced Parkinsonism. Clinicopathologic study of two cases", Arch Neurol, 39, pp.644~646 (1982)
4. Moreno JLLS, "Substantia nigra echogenicity predicts response to drug withdrawal in suspected drug-induced Parkinsonism", Mov Disord Clin Pract, 3, pp.268~274 (2016)
5. Bower JH, "Incidence and distribution of Parkinsonism in Olmsted County, Minnesota, 1976-1990", Neurology, 52, pp.1214~1220 (1999)
6. Erro R, "Parkinsonism following neuroleptic exposure : a double-hit hypothesis?", Mov Disord, 30, pp.780~785 (2015)
7. Lim TT, "Is 6 months of neuroleptic withdrawal sufficient to distinguish druginduced Parkinsonism from Parkinson’s disease?", Int J Neurosci, 123, pp.170~174 (2013)
8. Shin HW, "Drug-induced Parkinsonism", J Clin Neurol, 8, pp.15~21 (2012)
9. Inada T, "Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neurolepticinduced, treatment-resistant tardive dyskinesia", Pharmacogenet Genomics, 18, pp.317~323 (2008)
10. Byun JH, "Trends in the prevalence of drug-induced Parkinsonism in Korea", Yonsei Med J, 60, pp.760~767 (2019)
11. de Germay S, "Drug-induced Parkinsonism : revisiting the epidemiology using the WHO pharmacovigilance database", Parkinsonism Relat Disord, 70, pp.55~59 (2020)
12. Munhoz RP, "Not all drug-induced Parkinsonism are the same : the effect of drug class on motor phenotype", Neurol Sci, 38, pp.319~324 (2017)
13. Kim JS, "Nonmotor symptoms in druginduced Parkinsonism and drug-naïve Parkinson disease", Can J Neurol Sci, 40, pp.36~41 (2013)
14. Morley JF, "Motor and non-motor features of Parkinson’s disease that predict persistent drug-induced Parkinsonism", Parkinsonism Relat Disord, 20, pp.738~742 (2014)
15. World Health Organization, "Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement. World Health Organization heads of centres collaborating in WHO co-ordinated studies on biological aspects of mental illness", Br J Psychiatry, 156, pp.412~ (1990)

관련 논문AI추천